A detailed history of Choate Investment Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Choate Investment Advisors holds 67,743 shares of ABBV stock, worth $13.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
67,743
Previous 68,861 1.62%
Holding current value
$13.2 Million
Previous $12.5 Million 7.34%
% of portfolio
0.31%
Previous 0.34%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $173,055 - $202,089
-1,118 Reduced 1.62%
67,743 $11.6 Million
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $990,724 - $1.13 Million
-6,199 Reduced 8.26%
68,861 $12.5 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $212,729 - $239,583
1,546 Added 2.1%
75,060 $11.6 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $152,159 - $176,146
1,139 Added 1.57%
73,514 $11 Million
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $1.27 Million - $1.58 Million
9,606 Added 15.3%
72,375 $9.75 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $1.09 Million - $1.31 Million
7,907 Added 14.41%
62,769 $10.2 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $42,947 - $49,257
320 Added 0.59%
54,862 $7.36 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $4,266 - $5,423
31 Added 0.06%
54,542 $8.35 Million
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $200,477 - $248,736
-1,519 Reduced 2.71%
54,511 $8.84 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $19,229 - $24,331
-179 Reduced 0.32%
56,030 $7.59 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $29,153 - $33,093
274 Added 0.49%
56,209 $6.06 Million
Q2 2021

Jul 30, 2021

SELL
$105.21 - $117.21 $63,336 - $70,560
-602 Reduced 1.06%
55,935 $6.3 Million
Q1 2021

May 07, 2021

BUY
$102.3 - $112.62 $106,801 - $117,575
1,044 Added 1.88%
56,537 $6.12 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $11,510 - $15,539
-143 Reduced 0.26%
55,493 $5.95 Million
Q3 2020

Oct 26, 2020

SELL
$85.91 - $100.83 $24,656 - $28,938
-287 Reduced 0.51%
55,636 $4.87 Million
Q2 2020

Jul 23, 2020

SELL
$73.37 - $98.18 $16,141 - $21,599
-220 Reduced 0.39%
55,923 $5.49 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $33,088 - $50,166
-513 Reduced 0.91%
56,143 $4.28 Million
Q4 2019

Jan 28, 2020

SELL
$72.13 - $90.25 $226,343 - $283,204
-3,138 Reduced 5.25%
56,656 $5.02 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $191,207 - $229,885
-3,036 Reduced 4.83%
59,794 $4.53 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $150,650 - $192,566
-2,293 Reduced 3.52%
62,830 $4.57 Million
Q1 2019

Apr 29, 2019

BUY
$77.14 - $90.79 $158,059 - $186,028
2,049 Added 3.25%
65,123 $5.25 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $81,431 - $100,426
-1,046 Reduced 1.63%
63,074 $5.82 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $1.41 Million - $1.57 Million
-15,872 Reduced 19.84%
64,120 $6.06 Million
Q2 2018

Jul 30, 2018

SELL
$89.78 - $106.23 $1.84 Million - $2.17 Million
-20,441 Reduced 20.35%
79,992 $7.41 Million
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $406,776 - $544,711
-4,421 Reduced 4.22%
100,433 $0
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $708,777 - $777,233
-7,914 Reduced 7.02%
104,854 $0
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $7.88 Million - $10.1 Million
112,768
112,768 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Choate Investment Advisors Portfolio

Follow Choate Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.